Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Aethlon Medical (AEMD) over the last 15 years, with Q1 2025 value amounting to $248736.0.

  • Aethlon Medical's Change in Accured Expenses rose 111869.67% to $248736.0 in Q1 2025 from the same period last year, while for Mar 2025 it was -$53360.0, marking a year-over-year decrease of 13405.71%. This contributed to the annual value of -$53360.0 for FY2025, which is 13405.71% down from last year.
  • Per Aethlon Medical's latest filing, its Change in Accured Expenses stood at $248736.0 for Q1 2025, which was up 111869.67% from -$397466.0 recorded in Q4 2024.
  • Aethlon Medical's 5-year Change in Accured Expenses high stood at $540780.0 for Q1 2022, and its period low was -$397466.0 during Q4 2024.
  • Moreover, its 5-year median value for Change in Accured Expenses was -$25892.0 (2023), whereas its average is $5254.5.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first tumbled by 143509.19% in 2024, then skyrocketed by 111869.67% in 2025.
  • Quarter analysis of 5 years shows Aethlon Medical's Change in Accured Expenses stood at -$69219.0 in 2021, then soared by 540.01% to $304572.0 in 2022, then tumbled by 108.5% to -$25892.0 in 2023, then tumbled by 1435.09% to -$397466.0 in 2024, then skyrocketed by 162.58% to $248736.0 in 2025.
  • Its last three reported values are $248736.0 in Q1 2025, -$397466.0 for Q4 2024, and -$228406.0 during Q3 2024.